Azoy Alexander 4
4 · Arcus Biosciences, Inc. · Filed Aug 15, 2024
Insider Transaction Report
Form 4
Azoy Alexander
Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-08-13$14.97/sh−1,357$20,314→ 19,070 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.
- [F2]Consists of 1,357 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan.